Clinical Trial Update: Effect of Trimetazidine on Radiotherapy-induced Heart Damage. [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating the effect of trimetazidine on radiotherapy-induced heart damage in cardiotoxicity patients, with Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiotoxicity

Drugs mentioned

• Trimetazidine (trimetazidine)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Cardiotoxicity | Phase 2, Phase 3 | Status: UNKNOWN